Lupin Gets US FDA Approval for Oxcarbazepine ER Tablets

Lupin, a drug company, got a thumbs-up from the US government to sell a medicine called Oxcarbazepine.

This medicine helps stop seizures in people who are at least six years old.

It's a copy of another medicine already sold in the US.

Lupin's sales went up, but their profits were a bit lower than expected.

They made more money than last year and a bit more than the previous quarter.

The company's main market for sales was in North America, but they also had a lot of sales in growing markets and in India.